Cargando…

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells

Ebola virus (EBOV), a member of the mononegaviral family Filoviridae, causes severe disease associated with high lethality in humans. Despite enormous progress in development of EBOV medical countermeasures, no anti-EBOV treatment has been approved. We designed an immunotoxin in which a single-chain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yingyun, Yu, Shuiqing, Chi, Xiaoli, Radoshitzky, Sheli R., Kuhn, Jens H., Berger, Edward A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790382/ https://www.ncbi.nlm.nih.gov/pubmed/33411835 http://dx.doi.org/10.1371/journal.pone.0245024

Ejemplares similares

Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
por: Miller, Emily Happy, et al.
Publicado: (2011)

Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran
por: Kuhn, Jens H., et al.
Publicado: (2014)

Ebola virus, but not Marburg virus, replicates efficiently and without required adaptation in snake cells
por: Fedewa, Greg, et al.
Publicado: (2018)

On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization
por: Beitzel, Brett F., et al.
Publicado: (2021)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
por: Paparisto, Ermela, et al.
Publicado: (2021)

Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
por: Yi, Dongrong, et al.
Publicado: (2022)

Recombinant Antibodies to the Ebola Virus Glycoprotein
por: Panina, A. A., et al.
Publicado: (2017)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

Ebola virus disease
por: Jacob, Shevin T., et al.
Publicado: (2020)

EPS8 Facilitates Uncoating of Influenza A Virus
por: Larson, Gloria P., et al.
Publicado: (2019)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
por: Manno, Daniela, et al.
Publicado: (2022)

The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
por: Groseth, Allison, et al.
Publicado: (2012)

Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
por: Rodríguez-Martínez, Luis Mario, et al.
Publicado: (2015)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)

A small stem-loop structure of the Ebola virus trailer is essential for replication and interacts with heat-shock protein A8
por: Sztuba-Solinska, Joanna, et al.
Publicado: (2016)

Viral genomics in Ebola virus research
por: Di Paola, Nicholas, et al.
Publicado: (2020)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
por: Bennett, Ryan P., et al.
Publicado: (2020)

Recent successes in therapeutics for Ebola virus disease: no time for complacency
por: Iversen, Patrick L, et al.
Publicado: (2020)

Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model
por: Cooper, Timothy K., et al.
Publicado: (2018)

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2018)

An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion
por: Fénéant, Lucie, et al.
Publicado: (2019)

In silico-based vaccine design against Ebola virus glycoprotein
por: Dash, Raju, et al.
Publicado: (2017)

Ebola Virus Transmission Initiated by Systemic Ebola Virus Disease Relapse
por: Mbala-Kingebeni, Placide, et al.
Publicado: (2021)

Author Correction: Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model
por: Cooper, Timothy K., et al.
Publicado: (2019)

Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection
por: Kugelman, Jeffrey R., et al.
Publicado: (2012)

ISCB Ebola Award for Important Future Research on the Computational Biology of Ebola Virus
por: Karp, Peter D., et al.
Publicado: (2015)

ISCB Ebola Award for Important Future Research on the Computational Biology of Ebola Virus
por: Karp, Peter D., et al.
Publicado: (2015)

Ebola virus disease
por: Laupland, Kevin B, et al.
Publicado: (2014)

Ebola, the killer virus
por: Ghazanfar, Haider, et al.
Publicado: (2015)

Diagnostics of Ebola virus
por: Bettini, Aurora, et al.
Publicado: (2023)

Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
por: Kühl, Annika, et al.
Publicado: (2011)

Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
por: Wu, Shipo, et al.
Publicado: (2012)

Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic
por: Diehl, William E., et al.
Publicado: (2016)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
por: Zhu, Wenjun, et al.
Publicado: (2019)

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples
por: Postnikova, Elena N., et al.
Publicado: (2019)

Machupo Virus Glycoprotein Determinants for Human Transferrin Receptor 1 Binding and Cell Entry
por: Radoshitzky, Sheli R., et al.
Publicado: (2011)

Interferon-γ Inhibits Ebola Virus Infection
por: Rhein, Bethany A., et al.
Publicado: (2015)

Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease
por: Perry, Donna L., et al.
Publicado: (2018)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7kc9tbk08mfaufegjrdr6odjqa